Sarepta Therapeutics Inc
Biotechnology
Healthcare
SRPT
100.45 M shares
NASDAQ US
traded
14 Apr 2025
listed
no
open
53.34
52 week high
163.85
high
54.64
52 week low
49.30
low
51.39
growth
-55.70 %
previous Close
51.03
P/E ratio
market cap
11.61 B
div yield
0
net incoming
33.61 M
420.29 %
net profit margin
7.19 %
5.00 %
operating incoming
22.20 M
3.00 %
net change in cash
-170.19 M
-289.73 %
cash on hand
198 M
-48.42 %
cost of revenue
91.69 M
72.14 %
top
top